All Stories

  1. Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

    Article • OncoTargets and Therapy, January 2016, Dove Medical Press

    Dr Stephan T. Kiessig

  2. Judgement of the Court of Justice of the EU: Permanent Exclusion of MSM from Giving Blood

    Article • Transfusion Medicine and Hemotherapy, January 2016, Karger Publishers

    Dr Stephan T. Kiessig

  3. Donor hemovigilance evaluated from 1.1 million donations

    Article • Transfusion Medicine and Hemotherapy, January 2014, Karger Publishers

    Dr Stephan T. Kiessig

  4. The quality of plasma depends an the apheresis protocol in use

    Article • Transfusion, October 2012, Wiley

    Dr Stephan T. Kiessig

  5. Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting

    Article • Cancer Immunology Immunotherapy, October 2009, Springer Science + Business Media

    Dr Stephan T. Kiessig

  6. Mode-of-Action, Efficacy, and Safety of a Homologous Multi-Epitope Vaccine in a Murine Model for Adjuvant Treatment of Renal Cell Carcinoma

    Article • European Urology, July 2009, Elsevier

    Dr Stephan T. Kiessig

  7. Adjuvante autologe Tumorvakzine beim Nierenzellkarzinom

    Article • Der Urologe, June 2009, Springer Science + Business Media

    Dr Stephan T. Kiessig

  8. Human hybridomas derived from CDS+ B lymphocytes of patients with chronic lymphocytic leukemia (B-CLL) produce multi-specific natural IgM (kappa) antibodies

    Article • Clinical & Experimental Immunology, June 2008, Wiley

    Dr Stephan T. Kiessig

  9. Enzyme linked immunosorbent assay (ELISA) as screening method for anti-paternal allo-antibodies in patients with recurrent pregnancy loss (RPL)

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, February 2008, Elsevier

    Dr Stephan T. Kiessig

  10. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA)

    Article • Vox Sanguinis, August 2006, Wiley

    Dr Stephan T. Kiessig

  11. Serological Investigations of Red Foxes (Vulpes vulpes L.) for Determination of the Spread of Tick-borne Encephalitis in Northrhine-Westphalia

    Article • Journal of Veterinary Medicine Series B, September 2000, Wiley

    Dr Stephan T. Kiessig

  12. An Increased Serum Level of Free Apo(a) in Renal Patients Is More Striking than that of Lp(a) and Is Influenced by Homocysteine

    Article • January 2000, Karger Publishers

    Dr Stephan T. Kiessig

  13. The influence of citrate concentration on the quality of plasma obtained by automated plasmapheresis: a prospective study

    Article • Transfusion, November 1999, Wiley

    Dr Stephan T. Kiessig

  14. Unbound apo(a) in patients with kidney disease

    Article • Atherosclerosis, May 1999, Elsevier

    Dr Stephan T. Kiessig

  15. Detection of free Apo(a) has a higher specificity and sensitivty in CHD patients

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 1999, De Gruyter

    Dr Stephan T. Kiessig

  16. Diagnosis of tick-borne encephalitis: Evaluation of sera with borderline titers with the TBE-ELISA

    Article • Infection, September 1996, Springer Science + Business Media

    Dr Stephan T. Kiessig

  17. Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalence

    Article • Infection, September 1996, Springer Science + Business Media

    Dr Stephan T. Kiessig

  18. Purification and immunochemical characterization of a natural human polyreactive monoclonal IgM antibody

    Article • Journal of Immunological Methods, January 1994, Elsevier

    Dr Stephan T. Kiessig

  19. Immune Restoration in Children after Partial Splenectomy

    Article • Immunobiology, August 1993, Elsevier

    Dr Stephan T. Kiessig

  20. Enzyme immunoassay techniques an overview

    Article • Journal of Immunological Methods, June 1992, Elsevier

    Dr Stephan T. Kiessig

  21. IMMUNOGLOBULIN FRAGMENTS DURING FERMENTATION OF A HUMAN MONOCLONAL ANTI-ERYTHROCYTE ANTIBODY

    Article • January 1992, Elsevier

    Dr Stephan T. Kiessig

  22. SIMULTANEOUS CULTIVATION OF TWO HYBRIDOMA CELL LINES IN A HOLLOW FIBER BIOREACTOR

    Article • January 1992, Elsevier

    Dr Stephan T. Kiessig

  23. Human monoclonal IgM antibodies from foetal B-cell hybridomas directed against a surface antigen on human tumour cells

    Article • Research in Immunology, January 1992, Elsevier

    Dr Stephan T. Kiessig

  24. A solid-phase enzyme immunoassay for the detection of tetanus toxin using human and murine monoclonal antibodies

    Article • Journal of Basic Microbiology, January 1991, Wiley

    Dr Stephan T. Kiessig

  25. APPEARANCE OF NONSPECIFIC AMOUNTS OF MONOCLONAL ANTIBODY DURING FERMENTATION CAUSED BY DECREASED CELL VIABILITY

    Article • January 1991, Elsevier

    Dr Stephan T. Kiessig

  26. Development of a Solid Phase Enzyme Immunoassay for the Detection of Anti-Ro Autoantibodies

    Article • Scandinavian Journal of Rheumatology, January 1991, Taylor & Francis

    Dr Stephan T. Kiessig

  27. Development of Specific IgG-Producing Human Hybridomas by Fusions of Lymphocytes from Actively Immunized Persons

    Article • Hybridoma, October 1989, Mary Ann Liebert Inc

    Dr Stephan T. Kiessig

  28. Nachweis menschlicher anti-idiotypischer Antikörper mittels humaner monoklonaler Anti-DNA-Antikörper

    Article • January 1989, Springer Science + Business Media

    Dr Stephan T. Kiessig

  29. Monoklonale Antikörper gegen neuronenspezifische Enolase

    Article • January 1989, Springer Science + Business Media

    Dr Stephan T. Kiessig

  30. Multireaktivität oder Kreuzreaktivität monoklonaler Antikörper?

    Article • January 1989, Springer Science + Business Media

    Dr Stephan T. Kiessig

  31. Spezifische und polyspezifische humane monoklonale Antikörper

    Article • January 1989, Springer Science + Business Media

    Dr Stephan T. Kiessig

  32. Beladung von Polystyrol Festphasen mit mikrobiellen Erregern und deren Polysaccharid-Antigenen zum Screening monoklonaler Antikörper

    Article • Journal of Basic Microbiology, January 1989, Wiley

    Dr Stephan T. Kiessig

  33. Aufbau eines superschnellen Enzymimmunoassays für humane Cu/Zn Superoxid-Dismutase mit monoklonalen Antikörpern und Beispiele für seine klinische Anwendung

    Article • January 1989, Springer Science + Business Media

    Dr Stephan T. Kiessig

  34. The high efficiency, human B cell immortalizing heteromyeloma CB-F7

    Article • Journal of Immunological Methods, February 1988, Elsevier

    Dr Stephan T. Kiessig

  35. Establishment of human Ig producing heterohybridomas by fusion of mouse myeloma cells with human lymphocytes derived from peripheral blood, bone marrow, spleen, lymph node, and synovial fluid

    Article • Journal of Immunological Methods, February 1988, Elsevier

    Dr Stephan T. Kiessig

  36. Immunologische Veränderungen nach Milzteilresektion

    Article • January 1988, Springer Science + Business Media

    Dr Stephan T. Kiessig

  37. A myelopeptide from unstimulated bone marrow cells with immunomodulatory actiivity in lymphocyte cultures from healthy donors and patients with hypogammaglobulinemia and active systemic lupus erythematosus

    Article • International Journal of Immunopharmacology, January 1988, Elsevier

    Dr Stephan T. Kiessig

  38. Cell Biology of Human IgM-Producing Hybridomas Derived from a Fusion of Human Spleen Lymphocytes with Mouse Myeloma Cells

    Article • Hybridoma, December 1987, Mary Ann Liebert Inc

    Dr Stephan T. Kiessig

  39. The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesisin vitro

    Article • European Journal of Immunology, January 1987, Wiley

    Dr Stephan T. Kiessig